María del Rocío Juárez-Velázquez

Dr. María del Rocío Juárez-Velázquez

Instituto Nacional de Pediatria, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Hypertension Research
Verified
Journal Article
Closed access
PCPatricia Canto
Patricia Canto
TCThelma Canto-Cetina
Thelma Canto-Cetina
María del Rocío Juárez-VelázquezMaría del Rocío Juárez-Velázquez
María del Rocío Juárez-Velázquez
HRHaydee Rosas-Vargas
Haydee Rosas-Vargas
Hector Rangel-VillalobosHector Rangel-Villalobos
Hector Rangel-Villalobos
RCRamon Coral
Ramon Coral
Hypertension Research, official publication of the Japanese Society of Hypertension, publishes papers reporting original clinical and experimental research in the field of hypertension and related cardiovascular diseases.

1 October 2017 in Toxicology in Vitro
Verified
Journal Article
Closed access
MNM.P. Navarrete-Meneses
M.P. Navarrete-Meneses
CSConsuelo Salas
Consuelo Salas
MSM. Sanabrais-Jiménez
M. Sanabrais-Jiménez
JSJ. Santana-Hernández
J. Santana-Hernández
ASA. Serrano-Cuevas
A. Serrano-Cuevas
PPPatricia Pérez-Vera
Patricia Pérez-Vera

Verified
Journal Article
Open access
PDF file
DADANIEL ALEJANDRO MARTINEZ ANAYA
DANIEL ALEJANDRO MARTINEZ ANAYA
DLDafné Linda Moreno Lorenzana
Dafné Linda Moreno Lorenzana
ARAdriana Reyes-León
Adriana Reyes-León
UJUlises E Juárez-Figueroa
Ulises E Juárez-Figueroa
Michael DeanMichael Dean
Michael Dean
PPPatricia Pérez-Vera
Patricia Pérez-Vera
Ph-like subtypes with CRLF2 abnormalities are frequent among Hispano–Latino children with pre-B ALL. Therefore, there is solid ground to suggest that this subtype is frequent in Mexican patients. The genomic complexity of Ph-like subtype constitutes a challenge for diagnosis, as it requires diverse genomic methodologies that are not widely available in diagnostic centers in Mexico. Here, we propose a diagnostic strategy for Ph-like ALL in accordance with our local capacity. Pre-B ALL patients without recurrent gene fusions (104) were classified using a gene-expression profile based on Ph-like signature genes analyzed by qRT-PCR. The expressions of the CRLF2 transcript and protein were determined by qRT-PCR and flow cytometry. The P2RY8::CRLF2, IGH::CRLF2, ABL1/2 rearrangements, and Ik6 isoform were screened using RT-PCR and FISH. Surrogate markers of Jak2-Stat5/Abl/Ras pathways were analyzed by phosphoflow. Mutations in relevant kinases/transcription factors genes in Ph-like were assessed by target-specific NGS. A total of 40 patients (38.5%) were classified as Ph-like; of these, 36 had abnormalities associated with Jak2-Stat5 and 4 had Abl. The rearrangements IGH::CRLF2,P2RY8::CRLF2, and iAMP21 were particularly frequent. We propose a strategy for the detection of Ph-like patients, by analyzing the overexpression/genetic lesions of CRLF2, the Abl phosphorylation of surrogate markers confirmed by gene rearrangements, and Sanger sequencing.

7 May 2022 in Cytokine
Verified
Journal Article
Closed access
María del Rocío Juárez-VelázquezMaría del Rocío Juárez-Velázquez
María del Rocío Juárez-Velázquez
DMDafné Linda Moreno-Lorenzana
Dafné Linda Moreno-Lorenzana
DADaniel Alejandro Martínez Anaya
Daniel Alejandro Martínez Anaya
EMEduardo Adrián Hernández Monterde
Eduardo Adrián Hernández Monterde
MAMaría Montserrat Aguilar-Hernández
María Montserrat Aguilar-Hernández
PPPatricia Pérez-Vera
Patricia Pérez-Vera

1 September 2012 in Leukemia Research
Verified
Journal Article
Closed access
OROreth Montero Ruíz
Oreth Montero Ruíz
MOMiguel Angel Alcántara Ortigoza
Miguel Angel Alcántara Ortigoza
MBMiguel Betancourt
Miguel Betancourt
María del Rocío Juárez-VelázquezMaría del Rocío Juárez-Velázquez
María del Rocío Juárez-Velázquez
HGHumberto González-Márquez
Humberto González-Márquez
PPPatricia Pérez-Vera
Patricia Pérez-Vera

Verified
Journal Article
Open access
PDF file
MMMaria Del Pilar Navarrete Meneses
Maria Del Pilar Navarrete Meneses
CSConsuelo Salas
Consuelo Salas
María del Rocío Juárez-VelázquezMaría del Rocío Juárez-Velázquez
María del Rocío Juárez-Velázquez
DLDafné Linda Moreno Lorenzana
Dafné Linda Moreno Lorenzana
FGFernando Gómez-Chávez
Fernando Gómez-Chávez
PPPatricia Pérez-Vera
Patricia Pérez-Vera
The evidence supporting the biological plausibility of the association of permethrin and malathion with hematological cancer is limited and contradictory; thus, further studies are needed. This study aimed to investigate whether in vitro exposure to 0.1 μM permethrin and malathion at 0, 24, 48 and 72 h after cell culture initiation induced changes in the gene expression and DNA methylation in mononuclear cells from bone marrow and peripheral blood (BMMCs, PBMCs). Both pesticides induced several gene expression modifications in both tissues. Through gene ontology analysis, we found that permethrin deregulates ion channels in PBMCs and BMMCs and that malathion alters genes coding proteins with nucleic acid binding capacity, which was also observed in PBMCs exposed to permethrin. Additionally, we found that both insecticides deregulate genes coding proteins with chemotaxis functions, ion channels, and cytokines. Several genes deregulated in this study are potentially associated with cancer onset and development, and some of them have been reported to be deregulated in hematological cancer. We found that permethrin does not induce DNA hypermethylation but can induce hypomethylation, and that malathion generated both types of events. Our results suggest that these pesticides have the potential to modify gene expression through changes in promoter DNA methylation and potentially through other mechanisms that should be investigated.